KRAS and colorectal cancer: To examine the antitumor effect of HDACi in colorectal cancer, KRAS wild type(WiDR and HT29) and KRAS mutant cells (HCT116 and SW480) were treated with SAHAor cetuximab for 48 hours, and cell viability was measured.